Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Pharmaceuticals Regulation
55%
Drug Safety
45%
Prescription Drug
34%
Drug Screening
30%
Diseases
24%
Drug Approval
22%
Overall Survival
18%
Randomized Controlled Trial
17%
Alosetron
15%
Cohort Study
15%
Nomifensine
15%
Off-Label Use
15%
DRESS Syndrome
15%
Adverse Drug Reaction
15%
Practolol
15%
Althesin
15%
Cross Sectional Study
15%
Anticarcinogen
15%
Anticancer Drug
15%
Relenza
15%
Drug Induced Disease
15%
Drug Development
12%
Thalidomide
10%
Prevalence
7%
Disease Marker
7%
Sialidase Inhibitor
7%
Haemophilus Influenzae Type B Vaccine
7%
Pharmaceutical Market
5%
Hepatotoxicity
5%
Risk Communication
5%
Cardiotoxicity
5%
Anesthetic Agent
5%
Base
5%
Toxicology
5%
Medicine and Dentistry
Malignant Neoplasm
84%
Pharmaceuticals Regulation
53%
Public Health
42%
Medicine
40%
Cross Sectional Study
15%
Randomized Controlled Trial
15%
Occupational Health
15%
End of Life Care
15%
Drug Screening
15%
Zanamivir
15%
Antidepressant
15%
Althesin
15%
Health Care Cost
15%
Drug Induced Disease
15%
Drug Efficacy
14%
Decision Making
12%
Drug Safety
11%
Diseases
10%
Health Technology
8%
Personal Identification
7%
Risk Evaluation
7%
Technology Assessment
7%
Sialidase Inhibitor
7%
Drug Therapy
7%
Psychiatry
7%
Risk Communication
5%
Irritable Bowel Syndrome
5%
Cardiotoxicity
5%
Liver Toxicity
5%
Diabetes
5%
Patient Monitoring
5%
Toxicology
5%
Anesthesiology
5%
Anesthetic Agent
5%
Base
5%
Social Sciences
Legislation
83%
UK
79%
USA
61%
Scientists
30%
Comparative Analysis
27%
Pharmaceutical Industry
18%
Empirical Research
15%
Medical Profession
15%
Treatment of Patients
15%
Consumerism
15%
Scientific Innovations
15%
Terminal Care
15%
Occupational Health
8%
Public Archives
7%
Swedish
7%
Government Regulation
7%
Drug Control
7%
Political Culture
7%
Decision-Making Process
7%
Regulatory Agency
7%
